论文部分内容阅读
目的 膜性BCS行PTA术后长期随访 ,观察其疗效和并发症。方法 18例膜性BCS行PTA术后患者有较完整的随访资料 ,随访时间 :>8年 4例 ,5 8年 8例 ,35年 3例 ,13年 2例 ,<1年 1例。门诊随访行彩超检查 12例 ,电话或信访 6例。结果 18例患者术后 2 7d临床症状及体征减轻或消失 ,88.9% ( 16/18)的病人能从事体力劳动。 2例在术后即分别出现肺梗塞及心力衰竭 ,1例术后 1年出现再狭窄。结论 膜性BCS患者PTA治疗应是首选方法 ,术前术后抗凝药物的应用及术中球囊充分扩张破膜是预防再狭窄及血栓形成的主要方法。
The purpose of membrane BCS after long-term follow-up of PTA to observe its efficacy and complications. Methods 18 patients with membranous BCS had complete follow-up data after PTA. The follow-up time was> 8 years, 4 cases, 58 cases, 8 cases, 35 cases, 3 cases, 13 cases, 2 cases and 1 case <1 year. Out-patient follow-up color Doppler ultrasound examination in 12 cases, telephone or petition in 6 cases. Results The clinical symptoms and signs of 18 patients were relieved or disappeared on day 27 after operation, and 88.9% (16/18) of the patients could perform manual labor. Two cases showed pulmonary infarction and heart failure respectively after operation, and one case showed restenosis one year after operation. Conclusion PTA in patients with membranous BCS should be the preferred method. Preoperative and postoperative anticoagulant drugs and intraoperative balloon expansion and rupture are the main methods to prevent restenosis and thrombosis.